View Author
patient study treatment glioma tumour radiotherapy cancer glioblastoma survival trial temozolomide imaging grade phase oncol progression response therapy imatinib month analysis assessment brain toxicity technique chemotherapy outcome table radiation factor adjuvant blood volume ptk /zk perfusion activity review glioblastoma multiforme disease tissue concentration university tumours tumor value sagopilone increase change necrosis ffusion eortc research status adjuvant temozolomide number growth uptake resonance group contrast gbm da reardon c-methionine brain tumours follow-up hydroxyurea progression-free survival radiation necrosis study h 2201 expression image speci www.thelancet.com cycle tumour progression european resonance spectroscopy 1-weighted blood volume oncology permeability
5 Most Recent Publications
|
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
(Article)
Stupp, R. Tosoni, A. Bent, M.J. van den Bogdahn, U. Graaf, W.T.A. van der Yun, H.J. Gorlia, T. Lacombe, D. Brandes, A. Bromberg, J.E.C. Hau, P. Campone, M. Gijtenbeek, J. Frenay, M. Breimer, L. Wiesinger, H. Allgeier, A. |
2011-09-01
|
|
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
(Article)
Dhermain, F.G. Hau, P. Lanfermann, H. Jacobs, A.H. Bent, M.J. van den |
2010-09-01
|
|
EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma
(Article)
Brandes, A. Stupp, R. Hau, P. Lacombe, D. Gorlia, T. Tosoni, A. Mirimanoff, R.O. Kros, J.M. Bent, M.J. van den |
2010-01-01
|
|
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
(Article)
Reardon, D.A. Dresemann, G. Hau, P. Easaw, J. Gil, M. Tonn, J. Gijtenbeek, A. Schlegel, U. Bergstrom, P. Green, S. Weir, A. Nikolova, Z. Taillibert, S. Campone, M. Bent, M.J. van den Clement, P.M.J. Blomquist, E. Gordower, L. Schultz, H. Raizer, J. |
2009-12-01
|
|
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
(Article)
Stupp, R. Hegi, M.E. Hau, P. Brandes, A. Gijtenbeek, J. Marosi, C. Vecht, C.J. Mokhtari, K. Wesseling, P. Villa, S. Eisenhauer, E. Gorlia, T. Mason, W.P. Weller, M. Lacombe, D. Cairncross, J.G. Mirimanoff, R.O. Bent, M.J. van den Taphoorn, M.J. Janzer, R.C. Ludwin, S.K. Allgeier, A. Fisher, B. Belanger, K. |
2009-05-01
|
